NCT04721808View on ClinicalTrials.gov

A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

1,712

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

November 24, 2021

Study Completion Date

November 24, 2021

Conditions
Arthritis, Rheumatoid
Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY